XOMAP Q4 2016 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$309M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$524,000-98.9% YoY

Gross Profit

-$34M-6500.4% margin

Operating Income

-$17M-3331.9% margin

Net Income

-$17M-3335.9% margin

EPS (Diluted)

$-1.54

QoQ Revenue Growth

-17.5%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$29M

Total Liabilities

$76M

Stockholders' Equity

-$47M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$524,000	$48M	-98.9%
Gross Profit	-$34M	$45M	-175.3%
Operating Income	-$17M	$29M	-160.7%
Net Income	-$17M	$25M	-168.9%